Skip to main content
SpringerLink
Log in

Analysis of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Gene K121Q Polymorphism Association with Some Risk Factors of Atherosclerosis in Patients with Acute Coronary Syndrome

  • Published:
Cytology and Genetics Aims and scope Submit manuscript

Abstract

The present study was performed to investigate whether common single-nucleotide polymorphism K121Q (rs1044498) of the ENPP1 gene is associated with the known risk factors of atherosclerosis (overweight, dyslipoproteinemia, hypertension, diabetes, smoking, and hypercoagulability) in persons with acute coronary syndrome. Venous blood of 118 patients was genotyped for the polymorphism by PCR and restriction fragment length polymorphism method. In patients divided into two subgroups according to their genotype (KK and KQ + QQ), the statistically significant differences were revealed only for plasma LDL-cholesterol level and fibrinolytic activity. The carriers of minor allele (KQ + QQ) had lower LDL-cholesterol concentration and the time of fibrinolysis than the major allele homozygotes (KK). The division of patients into subgroups according to presence or absence of some risk factors for atherosclerosis showed no statistically significant differences between K121Q genotype distributions for any of the comparison.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morgan, T.M., Krumholz, H.M., Lifton, R.P., and Spertus, J.A., Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study, J. Am. Med. Ass., 2007, vol. 297, no. 14, pp. 1551–1561.

    Article  CAS  Google Scholar 

  2. Morgan, T.M., Xiao, L., Lyons, P., Kassebaum, B., Krumholz, H.M., and Spertus, J.A., Investigation of 89 candidate gene variants for effects on all-cause mortality following acute coronary syndrome, BMC Med. Genet., 2008, vol. 9, no. 7, pp. 66–74.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Morgan, T.M., House, J.A., Cresci, S., Jones, P., Allayee, H., Hazen, S.L., Patel, Y., Patel, R.S., Eapen, D.J., Waddy, S.P., Quyyumi, A.A., Kleber, M.E., Marz, W., Winkelmann, B.R., Boehm, B.O., Krumholz, H.M., and Spertus, J.A., Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome, BMC Med. Genet., 2011, vol. 12, no. 9, pp. 127–133.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Demer, L.L. and Tintut, Y., Inflammatory, metabolic, and genetic mechanisms of vascular calcification, Arterioscler. Thromb. Vasc. Biol., 2014, vol. 34, no. 4, pp. 715–723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lehto, S., Niskanen, L., Suhonen, M., Rönnemaa, T., and Laasko, I., Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus, Arterioscler. Thromb. Vasc. Biol., 1996, vol. 16, no. 8, pp. 978–983.

    Article  CAS  PubMed  Google Scholar 

  6. Goldfine, I.D., Maddux, B.A., Youngren, J.F., Reaven, G., Accili, D., Trischitta, V., Vigneri, R., and Frittitta, L., The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase/phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities, Endocr. Rev., 2008, vol. 29, no. 1, pp. 62–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shao, J.S., Cai, J., and Towler, D.A., Molecular mechanisms of vascular calcification: lessons learned from the aorta, Arterioscler. Thromb. Vasc. Biol., 2006, vol. 26, no. 7, pp. 1423–1430.

    Article  CAS  PubMed  Google Scholar 

  8. Abedin, M., Tintut, Y., and Demer, L.L., Vascular calcification. mechanisms and clinical ramifications, Arterioscler. Thromb. Vasc. Biol., 2004, vol. 24, no. 7, pp. 1161–1170.

    Article  CAS  PubMed  Google Scholar 

  9. Towler, D.A., Inorganic pyrophosphate. a paracrine regulator of vascular calcification and smooth muscle phenotype, Arterioscler. Thromb. Vasc. Biol., 2005, vol. 25, no. 4, pp. 651–654.

    Article  CAS  PubMed  Google Scholar 

  10. Johnson, K., Polewski, M., van Etten, D., and Terkeltaub, R., Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1–/–mice, Arterioscler. Thromb. Vasc. Biol., 2005, vol. 25, no. 4, pp. 686–691.

    Article  CAS  PubMed  Google Scholar 

  11. Pizzuti, A., Frittitta, L., Argiolas, A., Baratta, R., Goldfine, I.D., Bozzali, M., Ercolino, T., Scarlato, G., Iacoviello, L., Vigneri, R., Tassi, V., and Trischitta, V., A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance, Diabetes, 1999, vol. 48, no. 9, pp. 1881–1884.

    Article  CAS  PubMed  Google Scholar 

  12. Costanzo, B.V., Trischitta, V., Di Paola, R., Spampinato, D., Pizzuti, A., Vigneri, R., and Frittitta, L., The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121), Diabetes, 2001, vol. 50, no. 4, pp. 831–836.

    Article  CAS  PubMed  Google Scholar 

  13. Endler, G., Mannhalter, C., Sunder-Plassmann, H., Schillinger, I., Klimesch, A., Exner, M., Kapiotis, S., Meier, S., Kunz, F., Raiger, E., Huber, K., Wagner, O., and Sunder-Plassmann, R., The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction, J. Mol. Med, 2002, vol. 80, no. 12, pp. 791–795.

    Article  CAS  PubMed  Google Scholar 

  14. Bacci, S., Ludovico, O., Prudente, S., Zhang, Y.Y., Paola, R.D., Mangiacotti, D., Rauseo, A., Nolan, D., Duffy, J., Fini, G., Salvemini, L., Amico, C., Vigna, C., Pellegrini, F., Menzaghi, C., Doria, A., and Trischitta, V., The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction, Diabetes, 2005, vol. 54, no. 10, pp. 3021–3025.

    Article  CAS  PubMed  Google Scholar 

  15. Antman, E.M., Anbe, D.T., Armstrong, P.W., Aates, E.R., Green, L.A., Hand, M., Hochman, J.S., Krumholz, H.M., Kushner, F.G., Lamas, G.A., Mullany, C.J., Ornato, J.P., Pearle, D.L., Sloan, M.A., Smith, S.C., Jr., Alpert, J.S., Anderson, J.L., Faxon, D.P., Fuster, V., Gibbons, R.J., Gregoratos, G., Halperin, J.L., Hiratzka, L.F., Hunt, S.A., Jacobs, A.K., and Ornato, J.P., ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction, J. Am. Coll. Cardiol., 2004, vol. 44, no. 3, pp. 671–719.

    Article  PubMed  Google Scholar 

  16. Thygesen, K., Alpert, J., White, H., Jaffe, A.S., Apple, F.S., Galvani, M., et al., Universal definition of myocardial infarction, Eur. Heart. J., 2007, vol. 28, no. 20, pp. 2525–2538.

    Article  PubMed  Google Scholar 

  17. Terkeltaub, R.A., Inorganic pyrophosphate generation and disposition in pathophysiology, Am. J. Physiol. Cell Physiol., 2001, vol. 281, no. 1, pp. 1–11.

    Article  Google Scholar 

  18. Grupe, A., Alleman, J., Goldfine, I.D., Sadick, M., and Stewart, T.A., Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine, J. Biol. Chem., 1995, vol. 270, no. 38, pp. 22085–22088.

    Article  CAS  PubMed  Google Scholar 

  19. Chin, C.N., Dallas-Yang, Q., Liu, F., Ho, T., Ellsworth, K., Fischer, P., Natasha, T., Ireland, C., Lu, P., Li, C., Wang, I.M., Strohl, W., Berger, J.P., An, Z., Zhang, B.B., and Jiang, G., Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity, Eur. J. Pharmacol., 2009, vol. 606, nos. 1–3, pp. 17–24.

    Article  CAS  PubMed  Google Scholar 

  20. Maddux, B.A., Chang, Y.N., Accili, D., Mcguinness, O.P., Youngren, J.F., and Goldfine, I.D., Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia, Am. J. Physiol. Endocrinol. Metab., 2006, vol. 290, no. 4, pp. 746–749.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sumy State University, Sumy, 40007, Ukraine

    A. V. Ataman, V. Yu. Harbuzova, O. A. Obukhova & Ye. I. Dubovyk

Authors
  1. A. V. Ataman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Yu. Harbuzova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. A. Obukhova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ye. I. Dubovyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Yu. Harbuzova.

Additional information

Original Ukrainian Text © A.V. Ataman, V.Yu. Harbuzova, O.A. Obukhova, Ye.I. Dubovyk, 2018, published in Tsitologiya i Genetika, 2018, Vol. 52, No. 2, pp. 51–57.

The article was translated by the authors.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ataman, A.V., Harbuzova, V.Y., Obukhova, O.A. et al. Analysis of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Gene K121Q Polymorphism Association with Some Risk Factors of Atherosclerosis in Patients with Acute Coronary Syndrome. Cytol. Genet. 52, 127–131 (2018). https://doi.org/10.3103/S0095452718020020

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0095452718020020

Keywords

Search

Navigation